This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
MS in Pediatric Patients: Expert Guidance on Overcoming Challenges in Diagnosis and Treatment

MS in Pediatric Patients: Expert Guidance on Overcoming Challenges in Diagnosis and Treatment

Format

Webcast

Time to Complete

1 hour 25 minutes

Released

April 10, 2018

Expires

April 10, 2019
Add to Queue


Maximum Credits

1.25 / AMA PRA Category 1 Credit(s)TM

Accredited Provider



Jointly provided by Postgraduate Institute for Medicine and Enquiring Minds, LLC.

Commercial Supporter

Supported by an independent educational grant from Sanofi Genzyme

Program Description

Make real-world decisions and customize treatment plans in this dynamic case-based activity.

Intended Audience

This activity is intended for physicians and other clinicians engaged in the care of pediatric patients with multiple sclerosis (MS).

Educational Objectives

After completing this activity, participants should be better able to:

  • Assess and apply criteria for the diagnosis and monitoring of pediatric MS
  • Recommend tailored therapeutic strategies for children with MS using the most recent clinical evidence and individual patient characteristics

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Lauren B. Krupp, MD
Professor of Neurology
New York University
Director, MS Comprehensive Care Center
Director, Pediatric MS Center
NYU Langone Medical Center
New York, NY

Dr. Krupp discloses the following:
Royalty: Pfizer, Reata Pharma USA, AbbVie Pharmaceuticals, Amiscus Therapeutics, SA Inventions, Finkhar Health, Janssen Pharmaceuticals, Eisai, IPSOS, Octapharma, Atara Biotherapeutics, Merck, Research Tech, ERT
Consulting fees: Sanofi-Aventis, Biogen, Novartis, RedHill Biopharma, Everyday Heatlh, Shire, Gerson Lehman

Accreditor Disclosure

Planners and Managers
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP, have nothing to disclose.

The Enquiring Minds, LLC medical writers, Karen Chiu, MD, and Emma Nichols, PhD, have nothing to disclose.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

In order to receive credit, participants must complete the program evaluation. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact jkunst@pimed.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue